Biosynthetic L-theanine

L-theanine is γ-glutamylethylamide, a non-protein amino acid that accounts for a large share of the free amino acids in tea. It is not incorporated into proteins, and its structure — a glutamate backbone with an ethylamide in place of the usual amide — is what determines everything it does.

Made by an enzyme doing its side reaction

In the tea plant, theanine synthetase joins glutamate and ethylamine. Industrially, the more useful route exploits something else.

Glutaminase is named for hydrolysing glutamine to glutamate and ammonia. But like many hydrolases it is really transferring a γ-glutamyl group, and water is only its default acceptor. Supply a large excess of a better nucleophile — ethylamine — and the enzyme transfers the glutamyl group to that instead, producing theanine directly from cheap glutamine.

This is a general and underappreciated point about hydrolases: hydrolysis and transfer are the same chemistry with different acceptors, and the product is decided by what is available in excess. Driving a hydrolase backwards, or sideways, is often cheaper than finding a dedicated synthetase.

Stereochemistry matters here as it did for menthol. Only the L form is biologically relevant; chemical synthesis gives a racemate, and the D form is not the molecule the receptors and transporters recognise. An enzymatic route delivers the L form exclusively, which is its main advantage over synthesis.

How it reaches the brain

Theanine is structurally close to glutamine, and it crosses the blood–brain barrier using the large neutral amino acid transporter, LAT1 — the same carrier that moves leucine, phenylalanine, tryptophan and tyrosine.

That has a consequence worth knowing. LAT1 is saturable and its substrates compete, so theanine uptake depends on the concentrations of the other large neutral amino acids in plasma, which vary with a meal. It also means theanine can modestly interfere with the uptake of those amino acids, including tryptophan, the serotonin precursor.

What it appears to do, stated carefully

The most reproducible finding is electrophysiological: theanine increases alpha-band activity in the EEG, a pattern associated with relaxed wakefulness rather than drowsiness. This is measured rather than reported, which makes it the sturdiest part of the evidence.

Proposed mechanisms include weak antagonism at glutamate receptors — plausible given the structural similarity — and effects on GABA and dopamine. None is established well enough to present as the mechanism.

Behavioural evidence is thinner. Trials on anxiety, stress and sleep are mostly small, short and heterogeneous in dose and preparation, and effect sizes are modest.

The better-supported claim is combinational. Studies of theanine with caffeine consistently show improved attention-switching and reduced susceptibility to distraction compared with caffeine alone, and reduced jitteriness. The pharmacological reading is that caffeine’s arousal and theanine’s alpha-associated state are partly complementary. Since tea contains both, this is also the closest thing to a mechanistic account of why tea is described differently from coffee.

Doses used in trials are typically in the low hundreds of milligrams; brewed tea supplies considerably less per cup, which is the usual gap between the evidence and the product.